Pregnancy Exposure Registries

Pregnancy Exposure Registries

U.S. Food and Drug Administration

Do you know what a Pregnancy Exposure Registry is?

U.S. Food and Drug Administration

Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation

U.S. Food and Drug Administration

Teratogens and pharmacovigilance

The Global Health Network

Medication Safety in Pregnancy and Breast-feeding

University of California Television (UCTV)

COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER)

Surveillance of Emerging Threats to Pregnant Women

Centers for Disease Control and Prevention (CDC)

Zika Update: Findings from the US Zika Pregnancy Registry and Updated Clinical Guidance

Centers for Disease Control and Prevention (CDC)

Reviewing the Literature SSRIs in Pregnancy and Association with Autism

Psychopharmacology Institute

Pregnancy and Epilepsy

Epilepsy Foundation Eastern Pennsylvania

Lee Cohen - Pregnancy Registries — Risk-benefit of Psychotropics

CAUSALab at Harvard T.H. Chan

Teratovigilance capacity in Africa Halleux WHOTDR Central pregnancy registry

Global Pharmacovigilance

FDA Resources for Maternal Health

U.S. Food and Drug Administration

The effect of prenatal anti-seizure medication exposure on children: monotherapy versus dual therapy

Using Big Data to Study the Safety of Medications in Pregnancy | 2024 Perinatal Potpourri

Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials: Day 1

Post Approval pregnancy safety studies: Challenges and solutions

AWINSA Life Sciences

Medication safety in pregnancy

Shannon M. Clark, MD, MMS, FACOG

Lessons Learned with the Pregnancy and Lactation Labeling Rule (PLLR) (8/9) Labeling 2017

U.S. Food and Drug Administration

Former FDA Officer Breaks Down Truth about Gabapentin Label